The site of injection affects erythropoietin levels during dialysis

ASAIO Journal

Volumn 42, Issue 4, 1996, Pages 263-265

  Petersen, Jeffrey ^a   Kang, Michael S ^b   Yeh, Isabella ^b  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; BLOOD VESSELS; DISEASES; DRUG DOSAGE; DRUG INFUSION; PROTEINS;

ERYTHROPOIETIN; FRESENIUS DELIVERY SYSTEM; HEMODIALYSIS;

DIALYSIS;

RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG EFFICACY; ERYTHROPOIESIS; HEMATOCRIT; HEMODIALYSIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; MALE; TREATMENT OUTCOME;

ADULT; AGED; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROPOIETIN; HUMANS; INJECTIONS, INTRA-ARTERIAL; INJECTIONS, INTRAVENOUS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 0030200627     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002480-199607000-00006     Document Type: Article

References (8)

1. Eschbach JW, Abdulhadi MH, Browne JK, et al: Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a Phase III Multicenter Clinical Trial. Ann Intern Med 111: 992-100, 1989.
2. Petersen J, Yeh I, Hays MT: Erythropoietin can be administered during dialysis. Nephrol Dial Transplant 8: 962, 1993.
3. Macdougall IC, Roberts DE, Coles GA, Williams JD: Clinical pharmacokinetics of epoetin (recombinant human erythropoietin). Clin Pharmacokinetics 20: 99-113, 1991.
4. Koury MJ: Investigating erythropoietin resistance (Editorial). N Engl J Med 328: 205-206, 1993.
5. Eschbach JW, Haley NR, Adamson JW: New insights into the treatment of the anemia of chronic renal failure with erythropoietin. Semin Dial 3: 112-121, 1990.
6. Casati S, Passerinin P, Camise MR, et al: Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having dialysis. Br Med J 295: 1017-1020, 1987.
7. Muirhead N, Hodsman AB, Hollomby DJ, et al: The role of aluminum and parathyroid hormone in erythropoietin resistance in hemodialysis patients. Nephrol Dial Transplant 6: 342-345, 1991.
8. Rao DS, Mei-shu S, Mohini R: Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia. N Engl J Med 328: 171-175, 1993.